Citizens JMP analyst Roy Buchanan reiterated a Market Outperform rating and $5 price target on Arbutus Biopharma (NASDAQ: ABUS).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE